Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2953721 | 0.85 | LMNA (0.40) | MMEPOLBLMNAMEN1KMT2A | |
| SCHEMBL10336617 | 0.83 | MME (0.44) | MME | |
| SCHEMBL9638159 | 0.83 | MME (0.44) | MME | |
| SCHEMBL652495 | 0.81 | MEN1 (0.56) | MMEPOLBLMNAMEN1KMT2A | |
| SCHEMBL18117709 | 0.77 | CTSL (0.54) | MME | |
| SCHEMBL14580000 | 0.77 | CTSL (0.54) | MME | |
| SCHEMBL28514173 | 0.77 | MME (0.46) | MMEPOLBLMNAMEN1KMT2A | |
| SCHEMBL14579997 | 0.77 | CTSL (0.54) | MME | |
| SCHEMBL28481173 | 0.77 | AOC3 (0.47) | MMEPOLBLMNAMEN1KMT2A | |
| SCHEMBL6566164 | 0.76 | MME (0.45) | MMEPOLBLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071008-A1 | HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME | KUREHA CORPORATION (JP) | 2026-03-12 | — | — | US | disclosed |
| EP-4582460-A1 | HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME | Kureha Corporation (JP) | 2025-07-09 | — | — | EP | disclosed |
| WO-2024048610-A1 | HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME | 株式会社クレハ | 2024-03-07 | — | — | WO | disclosed |
| WO-2020026590-A1 | METHOD FOR PRODUCING POLY(ARYLENE SULFIDE) | 株式会社クレハ | 2020-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071008-A1 | HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME | GANAB, ALG1, GANC | MME 1528/4885POLB 2874/4885LMNA 617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.